SCHEMBL27385134

SCHEMBL27385134

c1cc(-c2ccc(N(c3ccccc3-c3ccc4c(c3)oc3ccccc34)c3cccc4oc5c6ccccc6ccc5c34)cc2)cc(-c2cccc3ccccc23)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.35
▸ PRKDC P78527 3/20 0.34
▸ CYP1A1 P04798 10/20 0.33
▸ CYP1B1 Q16678 10/20 0.33
▸ CYP1A2 P05177 9/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ ABCB1 P08183 2/20 0.32
▸ ABCC1 P33527 2/20 0.32
▸ ABCG2 Q9UNQ0 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384826 0.96 ALOX5 (0.37) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385132 0.96 ALOX5 (0.37) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385301 0.95 ALOX5 (0.35) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385126 0.95 CYP1A1 (0.36) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385101 0.95 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385137 0.95 ALOX5 (0.37) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385110 0.95 ALOX5 (0.37) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27386573 0.94 ALOX5 (0.36) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL24750071 0.94 ALOX5 (0.34) ALOX5PRKDCCYP1A1CYP1B1CYP1A2
SCHEMBL27385360 0.93 CYP1A1 (0.37) ALOX5PRKDCCYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215281-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-06-27 — — US disclosed
US-20240215281-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215281-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE OR10J3, L1CAM, RER1 ALOX5 2233/4885PRKDC 4518/4885CYP1A1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback